Evidence map›Paper›PMID 27933092›Full record

ArticleNutrition & metabolism2016

Effects of purified anthocyanin supplementation on platelet chemokines in hypocholesterolemic individuals: a randomized controlled trial.

Xiandan Zhang, Yanna Zhu, Fenglin Song, Yanling Yao, Fuli Ya, Dan Li, Wenhua Ling, Yan Yang

Open access · goldAbstract read
In one paragraph

Article in Nutrition & metabolism, 2016. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 26 papers, 4 of them syntheses that pooled it.

0numbers the graph read from it
0cells of the map it votes in
26citing papers in PubMed, 4 pooled it
2.5field-weighted citation impact, top 11% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

26 citing papers in PubMed, 4 syntheses or guidelines pooled it, 57 citations in OpenAlex.

  1. Pooled it
  2. Pooled it
  3. Pooled it
  4. Pooled it
  5. Trial
  6. Trial
  7. Article
  8. Review
  9. Review
  10. Review
  11. Review
  12. Article
  13. Review
  14. Review
  15. Article
  16. Review
  17. Review
  18. Article
  19. Review
  20. Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

8 authors at 2 institutions in 1 country.

Xiandan Zhang *Department of Nutrition, School of Public Health, Sun Yat-sen University (Northern Campus), Guangzhou, People's Republic of China.
Yanna Zhu *Department of Maternal and Child Health, School of Public Health, Sun Yat-sen University (Northern Campus), Guangzhou, People's Republic of China.
Fenglin SongSchool of Food Science, Guangdong Pharmaceutical University, Guangzhou, People's Republic of China.
Yanling YaoDepartment of Nutrition, School of Public Health, Sun Yat-sen University (Northern Campus), Guangzhou, People's Republic of China.
Fuli YaDepartment of Nutrition, School of Public Health, Sun Yat-sen University (Northern Campus), Guangzhou, People's Republic of China.
Dan LiDepartment of Nutrition, School of Public Health, Sun Yat-sen University (Northern Campus), Guangzhou, People's Republic of China.
Wenhua LingDepartment of Nutrition, School of Public Health, Sun Yat-sen University (Northern Campus), Guangzhou, People's Republic of China.
Yan YangDepartment of Nutrition, School of Public Health, Sun Yat-sen University (Northern Campus), Guangzhou, People's Republic of China.
Sun Yat-sen University · CNGuangdong Pharmaceutical University · CN

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

backgroundIt is becoming increasingly evident that platelet chemokines are involved in distinct aspects of atherosclerosis. The aim of this study was to examine the effects of long-term supplementation with purified anthocyanins on platelet chemokines in hypercholesterolemic individuals and to identify correlations of decreased platelet chemokine levels with serum lipid and inflammatory marker levels.

methodsA total of 146 hypercholesterolemic individuals were recruited and treated with 320 mg of purified anthocyanins (

resultsAnthocyanin supplementation for 24 weeks significantly decreased the plasma CXCL7 (-12.32% vs. 4.22%,

conclusionsThe present study supports the notion that platelet chemokines are promising targets of anthocyanins in the prevention of atherosclerosis.

trial registrationChiCTR-TRC-08000240. Registered: 10 December 2008.

Indexed as

AnthocyaninsCXCL7HypercholesterolemiaInflammationPlatelet chemokinesSerum lipids

Identifiers

PMID27933092
PMCPMC5124283
OpenAlexW2554382664

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.